Clinical Trials
33 trialsPediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
St. Jude Children's Research Hospital
PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND
Heinrich-Heine University, Duesseldorf
ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
Memorial Sloan Kettering Cancer Center
Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma
City of Hope Medical Center
GynECT
Institute of Oncology Ljubljana
TXCH-HD-12A
Baylor College of Medicine
Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
St. Jude Children's Research Hospital
BREACH
The Lymphoma Academic Research Organisation
Elechtra
IRCCS Azienda Ospedaliero-Universitaria di Bologna
BRAPP2
The Lymphoma Academic Research Organisation
Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Alliance for Clinical Trials in Oncology
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
Stanford University
Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor
Samsung Medical Center
(Optimist)
King Abdullah International Medical Research Center
nECT
Zealand University Hospital
Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma
Lymphoma Study Association
Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
Stanford University
Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma
Ohio State University Comprehensive Cancer Center
A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years
Newcastle-upon-Tyne Hospitals NHS Trust
Electrochemotherapy on Head and Neck Cancer
Rigshospitalet, Denmark
Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma
Samsung Medical Center
A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)
Memorial Sloan Kettering Cancer Center
Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease
Stanford University
Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects.
Copenhagen University Hospital at Herlev
Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Rituximab and ABVD for Hodgkin's Patients
M.D. Anderson Cancer Center
Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease
M.D. Anderson Cancer Center
Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
M.D. Anderson Cancer Center
Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy
Copenhagen University Hospital at Herlev
Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease
American Scitech International
Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma
Case Comprehensive Cancer Center